Skip to content

Effect of unani medicine in the management of bronchial asthma with allergic rhinitis

Clinical evaluation of safety and efficacy of Arq e Parsiaoshan in the management of Diq Al Nafas Hamrah Anfi Besh Hassasiyat - Bronchial Asthma With Concomittan Allergic Rhinitis : A Single Blind Randomised Controlled Study - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/086907
Enrollment
40
Registered
2025-05-14
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J453- Mild persistent asthma

Interventions

Intervention1: ARQ e PARSIAOSHAN: 25ml BD with water Before meals for 42 days with 6 follow ups Control Intervention1: LAUQ E KATAN: 10gms BD with Water for 42 days with 6 follow ups

Sponsors

Govt Nizamia tibbi college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects with co comittant AR 3 Subjects in stable state of asthma uncomplicated 4 ASSESS Score ASthma SEverity Scoring System within 10 points out of 20 points in index

Exclusion criteria

Exclusion criteria: Subjects with other co-morbidites like cardiac diseases DM or uncontrolled HTN BP greater than 150 by 100mmHg Subjects with TB COPD cardiac asthma severe anaemia Hb 7gm Immunocompromised patients with HIV Carcinomas Patients with H O participation in other study within last 2 3 months Subjects with derrandged vital functioning LFT RFT either known incidental finding Subjects with other atopy Dermatitis along asthma Pregnancy and lactation

Design outcomes

Primary

MeasureTime frame
ASSESS Score ASthma SEverity Scoring System within 10 points out of 20 points in index Timepoint: ASSESS Score ASthma SEverity Scoring System within 10 points With in 6 weeks

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactDr Mohammad Ahsan Farooqui

Government Nizamia Tibbi College and General Hospital

dr.faroqui@gmail.com9849139356

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026